@inbook{a92a8ff7b8ca47539324ca333400b16e,
title = "Central Nervous System Stimulants and Drugs That Suppress Appetite",
abstract = "The Side Effects of Drugs Annuals forms a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. The purpose of this supplement is to provide a concise reference of the newly available literature to support the existing information regarding the known adverse effects of commonly prescribed medications or abused drugs. The information covers peer-reviewed publications from January 2016 to December 2016. This review focused on CNS stimulants and drugs that suppress appetite. It covers amphetamines (including lisdexamfetamine, methamphetamine and 3,4-methylenedioxymetamphetamine), methylphenidate, atomoxetine, modafinil and armodafinil, methylxanthines (caffeine), monotherapies and combinational therapies that suppress appetite (lorcaserin, phentermine, phentermine/topiramate) and medications used in Alzheimer's disease and cognitive decline (rivastigmine, donepezil and memantine).",
keywords = "Adverse reactions, Alzheimer's disease, Amfetamine, Amphetamines, Appetite suppressants, Armodafinil, Atomoxetine, Caffeine, Contrave, Donepezil, Galantamine, Lisdexamfetamine, Lorcaserin, Metamfetamine, Methylphenidate, Methylxanthines, Modafinil, Phentermine, Qsymia, Rivastigmine, Treatment emergent adverse effects",
author = "Bello, {Nicholas T.} and Zahner, {Matthew R.}",
note = "Publisher Copyright: {\textcopyright} 2017 Elsevier B.V.",
year = "2017",
doi = "10.1016/bs.seda.2017.07.007",
language = "English (US)",
series = "Side Effects of Drugs Annual",
publisher = "Elsevier B.V.",
pages = "1--8",
booktitle = "Side Effects of Drugs Annual",
}